SCHEMBL31663565

SCHEMBL31663565

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(-c2ccccc2-c2cccc(C#N)c2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 4/20 0.41
RXFP1 Q9HBX9 1/20 0.41
HPGD P15428 5/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDE9A O76083 1/20 0.36
PDE1C Q14123 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
GAA P10253 3/20 0.36
MAPK1 P28482 2/20 0.36
GALR3 O60755 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PDE10A Q9Y233 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31272663 0.97 PDE9A (0.39) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL31663611 0.96 ALDH1A1 (0.41) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL31273030 0.93 PDE9A (0.39) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL31663554 0.92 PDE9A (0.40) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL31663632 0.92 PDE9A (0.40) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL23296325 0.90 PTGDR2 (0.36) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL17949571 0.88 ESR2 (0.40) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL24547907 0.85 PDE9A (0.40) ALDH1A1KDM4ERXFP1HPGDCYP1A2
SCHEMBL31663539 0.84 KDM4E (0.39) ALDH1A1KDM4EHPGDCYP2C9MAPK1
SCHEMBL31663564 0.83 PDE9A (0.38) ALDH1A1KDM4ERXFP1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885KDM4E 4364/4885RXFP1 4044/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885KDM4E 4364/4885RXFP1 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.